Functional impairment of dendritic cells caused by murine hepatocellular carcinoma

Journal of Clinical Immunology

Volumn 24, Issue 2, 2004, Pages 145-154

  Lee, Wei Chen ^a   Chiang, Yang Jen ^a   Wang, Hui Chuan ^a   Wang, Min Ru ^a   Lia, Shin Ru ^a   Chen, Miin Fu ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Dendritic cells; Hepatocellular carcinoma; IL 10

Indexed keywords

INTERLEUKIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HELPER CELL; HEPATOMA CELL; IMMUNOSURVEILLANCE; LIVER CELL CARCINOMA; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; TUMOR ESCAPE;

ANIMALS; ANTIGENS, NEOPLASM; BONE MARROW CELLS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; GENES, MHC CLASS II; INTERLEUKIN-10; LIVER NEOPLASMS; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL;

EID: 1842555499     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOCI.0000019779.56180.a2     Document Type: Article

References (32)

1. Chen Q, Daniel V, Maher DW, Hersey P: Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated by melanoma. Int J Cancer 56:755-760, 1994
2. Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, Gentilini O, Braga M: Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lens 104:1-5, 1996
3. Salazar-Onfray F: Interleukin-10: A cytokine used by tumors to escape immunosurveillance. Med Oncol 16:86-94, 1999
4. Schmid P, Itin P, Rufli T: In situ analysis of transforming growth factor-betas (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma. Carcinogenesis 16:1499-1503, 1995
5. de Visser KE, Kast WM: Effects of TGF-beta on the immune system: Implications for cancer immunotherapy. Leukemia 13:1188-1199, 1999
6. Wojtowicz-Praga S: Reversal of tumor-induced immunosuppression: A new approach to cancer therapy. J Immunother 20:165-177, 1997
7. Gold LI: The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncog 10:303-360, 1999
8. Gabrilovich DI, Chen L, Girgis KR, Cunningham T, Meny GM, Nadaf S, Kavanaugh D, Carbone DP: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2:1096-1103, 1996
9. Whiteside TL: Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol Immunother 48:346-352, 1999
10. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas-mediated T Cell killing by colon cancer cells expressing fas ligand. J Exp Med 184:1075-1082, 1996
11. O'Connell J, Bennett MW, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Cancer as a site of immune privilege. Immunol Today 20:47-53, 1999
12. Walker PR, Saas P, Dietrich PY: Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 158:4521-4524, 1997
13. Moller P, Hammerling GJ: The role of surface HLA-A,B,C molecules in tumour immunity. Cancer Surv 13:101-127, 1992
14. Shurin MR: Dendritic cells presenting tumor antigen. Cancer Immunol Immunother 43:158-164, 1996
15. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16, 1997
16. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245-252, 1998
17. Savary CA, Grazziutti ML, Melichar B, Przepiorka D, Freedman RS, Cowan RE, Cohen DM, Anaissie EJ, Woodside DG, McIntyre BW, Pierson DL, Pellis NR, Rex JH: Multidimensional flow-cytometric analysis of dendritic cells in peripheral blood of normal donors and cancer patients. Cancer Immunol Immunother 45:234-240, 1998
18. Maehara Y, Tomisaki S, Oda S, Kakeji Y, Tsujitani S, Ichiyoshi Y, Akazawa K, Sugimachi K: Lymph node metastasis and relation 10 tumour growth potential and local immune response in advanced gastric cancer. Int J Cancer 74:224-228, 1997
19. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K: The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 54:1461-1465, 1984
20. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693-1702, 1992
21. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63, 1983
22. Denizot F, Lang R. Rapid colorimetric assay for cellular growth and survival: Modifications 10 the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277, 1986
23. Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF: A novel technique for fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods 249:99-110, 2001
24. Hersey P: Impediments to successful immunotherapy. Pharmacol Ther 81:111-119, 1999
25. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 60:1539-1545, 1995
26. -) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62:659-665, 1996
27. Malefyt RW, Haanen J, Spits H, Roncarolo Maria-Grazia, Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924, 1991
28. Qin Z, Noffz G, Mohaupt M, Blankenstein T: Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J Immunol 159:770-776, 1997
29. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH: Induction of tolerance by IL-10-treated dendritic cells. J Immunol 159:4772-4780, 1997
30. Enk AH, Angeloni VL, Udey MC, Katz SI: Inhibition of Langerhans cell antigen-presenting function by IL-10. J Immunol 151:2390-2398, 1993
31. Hagenhaugh A, Sharma S, Dubinett SM, Wei SHY, Aranda R, Cheroutre H, Fowell DJ, Binder S, Tsao B, Locksley RM, Moore KW, Kronenberg M: Altered immune responses in interleukin 10 transgenic mice. J Exp Med 185:2101-2110, 1997
32. Sharma S, Stolina M, Lin Y, Gardner B, Miller PW, Kronenberg M, Dubinett SM: T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function. J Immunol 163:5020-5028, 1999